Disease, Disability, and Injury Prevention and Control, 9018 [2011-3525]

Download as PDF 9018 Federal Register / Vol. 76, No. 32 / Wednesday, February 16, 2011 / Notices ESTIMATED ANNUALIZED BURDEN TABLE—Continued Type of respondent Number of respondents Data collection name Number of responses per respondent Average burden per response (in hrs.) Total burden hours Trainer Exit Survey Satisfaction Interview—Post only pilot study. Trainer Feedback Forms (up to 10 forms)—Full Evaluation. Total Project Burden Hours .......... 10 1 30/60 5 30 10 5/60 25 ........................................................ ........................ ........................ ........................ 1,464 Seleda Perryman, Office of the Secretary, Paperwork Reduction Act Clearance Officer. [FR Doc. 2011–3442 Filed 2–15–11; 8:45 am] BILLING CODE 4150–33–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: February 4, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention mstockstill on DSKH9S0YB1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine Effectiveness for Preventing LaboratoryConfirmed Influenza in the United States, Funding Opportunity Announcement (FOA), IP11–003, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., April 7, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Annual Estimates of Influenza Vaccine Effectiveness for Preventing LaboratoryConfirmed Influenza in the United States, FOA IP11–003.’’ Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, VerDate Mar<15>2010 17:10 Feb 15, 2011 Jkt 223001 Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. [FR Doc. 2011–3525 Filed 2–15–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Emerging Infections Sentinel Network (EISN) Research, Funding Opportunity Announcement (FOA), CK11–002, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the aforementioned meeting: Times and Dates: 12 p.m.–2 p.m., March 29, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Emerging Infections Sentinel Network (EISN) Research, FOA CK11–002, initial review.’’ PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 Contact Person for More Information: Gregory Anderson, MS, MPH, Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 4, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–3529 Filed 2–15–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting Name: ICD–9–CM Coordination and Maintenance Committee meeting. Times and Dates: 9 a.m.–5:30 p.m., March 9, 2011. 9 a.m.–5:30 p.m., March 10, 2011. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. Security Considerations: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 76, Number 32 (Wednesday, February 16, 2011)]
[Notices]
[Page 9018]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3525]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control

    Special Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine 
Effectiveness for Preventing Laboratory-Confirmed Influenza in the 
United States, Funding Opportunity Announcement (FOA), IP11-003, 
Initial Review
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 8 a.m.-5 p.m., April 7, 2011 (Closed).
    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, 
Atlanta, Georgia 30337, Telephone: (770) 997-1100.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Annual Estimates of Influenza Vaccine Effectiveness for Preventing 
Laboratory-Confirmed Influenza in the United States, FOA IP11-003.''
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498-2293. The 
Director, Management Analysis and Services Office, has been delegated 
the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: February 4, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-3525 Filed 2-15-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.